TOP TIERMARKET NEWSWIRE
SEC Form 4 history

RHYTHM PHARMACEUTICA (RYTM) insider trades

RHYTHM PHARMACEUTICA (RYTM) insider trading activity (SEC Form 4). Over the trailing 90 days, RYTM insiders filed 0 purchases totalling $0 and 6 sales totalling $28.8M — net SELLING of $28.8M. Most recent filing: Sep 14, 2026. Insider transactions are a Pro-tier alertable signal in the live Top Tier Newswire terminal — Form 4 filings reach the wire within minutes of acceptance by the SEC. Data shown publicly here is delayed 4 hours.

Public view, delayed 4h. Real-time alerting on insider filings is a Pro feature.Open in the live terminal →
Buys (90d)
0
$0
Sells (90d)
6
$28.8M
Net (90d)
-$28.8M
net selling
Most recent
Sep 14, 2026

Recent transactions

FiledInsiderRoleTypeSharesPriceValue
Sep 14, 2026Meeker David PPres, CEOS SaleOE—$102.67$5.1Mfiling
Sep 1, 2026Smith Hunter CCFOS SaleOE—$105.46$6.6Mfiling
Aug 17, 2026Shulman JosephChief Technical OfficerS SaleOE—$119.75$608Kfiling
Aug 17, 2026Garfield AlastairChief Scientific OfficerS Sale—$117.57$913Kfiling
Aug 14, 2026Lee Jennifer KaydenEVP, Head of North AmericaS SaleOE—$117.38$8.9Mfiling
Aug 14, 2026Mazabraud YannEVP, Head of InternationalS SaleOE—$116.15$6.6Mfiling
Jun 24, 2026Tetrault Lynn A.DirS SaleOE—$100.32$3.7Mfiling
May 19, 2026German Christopher PaulCorporate Controller, CAOS SaleOE—$92.21$428Kfiling